-
1 Comment
Check-Cap Ltd is currently in a long term downtrend where the price is trading 6.6% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Check-Cap Ltd's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has dropped by 2.1% to $-4M since the same quarter in the previous year.
Finally, its free cash flow fell by 6.4% to $-4M since the same quarter in the previous year.
Based on the above factors, Check-Cap Ltd gets an overall score of 1/5.
Exchange | NASDAQ |
---|---|
CurrencyCode | USD |
ISIN | IL0011336851 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Market Cap | 4M |
---|---|
PE Ratio | None |
Target Price | 7 |
Beta | -0.26 |
Dividend Yield | None |
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CHEK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025